News

Polycythemia vera is a myeloproliferative, potentially fatal disease which manifests itself in the form of an overabundance of blood cells and platelets in the body resulting in heart

Cabozantinib is an inhibitor of tumor growth, metastasis and angiogenesis. It simultaneously targets MET and VEGFR2 – key kinases involved in the development and progression of many cancers.

Urocidin is a formulation of MCC, a sterile mycobacterial cell wall-DNA complex composition that acts dually to stimulate immunity as well as exert direct anticancer activity, and is

The move is a result of the company’s desire to effectively respond to the increased demand the Southern California region is experiencing by virtue of many life sciences

The solution helps promote member behavioral changes in areas of compliance, formulary management, therapeutic alternatives and disease state management. The Targeted Intervention Strategies gives a greater degree of

CTS-1027 is an oral, small molecule compound that inhibits the activity of key members of a class of protease enzymes, the matrix metalloproteinases (MMPs). The trial will evaluate

The MiStent DES employs Micell’s proprietary supercritical fluid technology which applies a precisely controlled absorbable polymer – active drug (sirolimus) matrix onto a cobalt-chromium stent. DESSOLVE II is

Both Element Systems incorporate the same novel platinum chromium (PtCr) alloy, stent design and advanced catheter delivery system, and represent the company’s third-generation drug-eluting stent (DES) technology. The

The tour is part of a 2010 partnership between Mannatech and the International Sport Karate Association (ISKA). The one-year North American campaign is scheduled to commence from 25